Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital

被引:26
作者
van den Berg, J. S. P. [1 ]
de Jong, G. [1 ]
机构
[1] Isala Klin, Dept Neurol, NL-8011 JW Zwolle, Netherlands
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 120卷 / 03期
关键词
ischemic stroke; intravenous thrombolysis; outcome; MODIFIED RANKIN SCALE; TRIALS; THERAPY;
D O I
10.1111/j.1600-0404.2008.01140.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives - To determine the proportion of patients with an ischemic stroke that received intravenous (IV) thrombolytic treatment, and reasons why patients are not treated. Methods - A prospective registry of all patients with an ischemic stroke admitted to our emergency department (ED). Results - A total of 286 patients with an ischemic stroke were admitted. Eighty-one patients were admitted within 3 h of onset of neurological deficit, of which 28 received IV thrombolysis. In 25 patients no thrombolytic treatment was given because of the presence of the National Institute of Neurological Disorders and Stroke (NINDS) exclusion criteria, and one patient refused treatment. No thrombolytic treatment was given to 27 patients because of mild neurological deficit or rapid clinical improvement, and after 3 months all these patients were independently living at home without nursing help. Despite a public campaign to gain awareness concerning stroke, the majority of the patients arrived too late at the ED for thrombolytic treatment. Conclusions - A large proportion of the patients with an ischemic stroke are admitted too late to receive IV thrombolysis. More needs to be done to increase both public and medical awareness of stroke as a treatable emergency.
引用
收藏
页码:157 / 160
页数:4
相关论文
共 13 条
[1]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[2]  
Boiten J, 2000, Ned Tijdschr Geneeskd, V144, P1062
[3]   DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke [J].
Diener, Hans-Christoph ;
Schneider, Dietmar ;
Lampl, Yair ;
Bornstein, Natan M. ;
Kozak, Alexander ;
Rosenberg, Gilad .
STROKE, 2008, 39 (06) :1774-1778
[4]   Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study [J].
Dirks, Maaike ;
Niessen, Louis W. ;
Koudstaal, Peter J. ;
Franke, Cees L. ;
van Oostenbrugge, Robert J. ;
Dippel, Diederik W. J. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (07) :685-689
[5]   Stroke [J].
Donnan, Geoffrey A. ;
Fisher, Marc ;
Macleod, Malcolm ;
Davis, Stephen M. .
LANCET, 2008, 371 (9624) :1612-1623
[6]  
Hacke W, 2004, LANCET, V363, P768
[7]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[8]   Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study [J].
Murray, CJL ;
Lopez, AD .
LANCET, 1997, 349 (9063) :1436-1442
[9]   Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries [J].
Palmer, AJ ;
Valentine, WJ ;
Roze, S ;
Lammert, M ;
Spiesser, J ;
Gabriel, S .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (01) :19-26
[10]   Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials [J].
Saver, Jeffrey L. .
STROKE, 2007, 38 (11) :3055-3062